285 related articles for article (PubMed ID: 8893066)
1. Acarbose: an alpha-glucosidase inhibitor.
Martin AE; Montgomery PA
Am J Health Syst Pharm; 1996 Oct; 53(19):2277-90; quiz 2336-7. PubMed ID: 8893066
[TBL] [Abstract][Full Text] [Related]
2. A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.
Santeusanio F; Compagnucci P
Drug Saf; 1994 Dec; 11(6):432-44. PubMed ID: 7727053
[TBL] [Abstract][Full Text] [Related]
3. Acarbose. An update of its pharmacology and therapeutic use in diabetes mellitus.
Balfour JA; McTavish D
Drugs; 1993 Dec; 46(6):1025-54. PubMed ID: 7510610
[TBL] [Abstract][Full Text] [Related]
4. Acarbose: its role in the treatment of diabetes mellitus.
Campbell LK; White JR; Campbell RK
Ann Pharmacother; 1996 Nov; 30(11):1255-62. PubMed ID: 8913408
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with acarbose as first line therapy in NIDDM.
Fölsch UR
Clin Invest Med; 1995 Aug; 18(4):312-7. PubMed ID: 8549018
[TBL] [Abstract][Full Text] [Related]
6. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
7. Effects of beano on the tolerability and pharmacodynamics of acarbose.
Lettieri JT; Dain B
Clin Ther; 1998; 20(3):497-504. PubMed ID: 9663365
[TBL] [Abstract][Full Text] [Related]
8. alpha-Glucosidase inhibitors in diabetes: efficacy in NIDDM subjects.
Toeller M
Eur J Clin Invest; 1994 Aug; 24 Suppl 3():31-5. PubMed ID: 8001625
[TBL] [Abstract][Full Text] [Related]
9. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of acarbose in diabetes mellitus: a critical review of controlled trials.
Scheen AJ
Diabetes Metab; 1998 Sep; 24(4):311-20. PubMed ID: 9805641
[TBL] [Abstract][Full Text] [Related]
11. A review of the safety and efficacy of acarbose in diabetes mellitus.
Yee HS; Fong NT
Pharmacotherapy; 1996; 16(5):792-805. PubMed ID: 8888075
[TBL] [Abstract][Full Text] [Related]
12. Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study.
Coniff RF; Shapiro JA; Robbins D; Kleinfield R; Seaton TB; Beisswenger P; McGill JB
Diabetes Care; 1995 Jun; 18(6):817-24. PubMed ID: 7555508
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.
Chiasson JL; Josse RG; Hunt JA; Palmason C; Rodger NW; Ross SA; Ryan EA; Tan MH; Wolever TM
Ann Intern Med; 1994 Dec; 121(12):928-35. PubMed ID: 7734015
[TBL] [Abstract][Full Text] [Related]
14. Acarbose: a review of US clinical experience.
Coniff R; Krol A
Clin Ther; 1997; 19(1):16-26; discussion 2-3. PubMed ID: 9083705
[TBL] [Abstract][Full Text] [Related]
15. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
16. The role of acarbose in the treatment of non-insulin-dependent diabetes mellitus.
Hanefeld M
J Diabetes Complications; 1998; 12(4):228-37. PubMed ID: 9647342
[TBL] [Abstract][Full Text] [Related]
17. [The use of the alpha-glucosidase inhibitor acarbose for the treatment of type-2 diabetes mellitus in secondary sulfanilamide resistance].
Gendeleka GF
Lik Sprava; 1997; (6):105-7. PubMed ID: 9589946
[TBL] [Abstract][Full Text] [Related]
18. Acarbose treatment of sulfonylurea-treated non-insulin dependent diabetics. A double-blind cross-over comparison of an alpha-glucosidase inhibitor with metformin.
Johansen K
Diabete Metab; 1984 Oct; 10(4):219-23. PubMed ID: 6391973
[TBL] [Abstract][Full Text] [Related]
19. New horizons in diabetes therapy--alpha glucosidase inhibitors.
Jawad F
J Pak Med Assoc; 1994 Mar; 44(3):59-60. PubMed ID: 8040998
[No Abstract] [Full Text] [Related]
20. Long-term efficacy and safety of acarbose in the treatment of obese subjects with non-insulin-dependent diabetes mellitus.
Coniff RF; Shapiro JA; Seaton TB
Arch Intern Med; 1994 Nov; 154(21):2442-8. PubMed ID: 7979840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
